Early reduction in PD-L1 expression predicts faster treatment response in human cutaneous leishmaniasis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Early reduction in PD-L1 expression predicts faster treatment response in human cutaneous leishmaniasis

Published:2021-11-15 Issue:22 Volume:131 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Dey Nidhi S.^ORCID,Senaratne Sujai,Somaratne Vijani,Madarasinghe Nayani P.^ORCID,Seneviratne Bimalka,Forrester Sarah^ORCID,Montes de Oca Marcela^ORCID,Reis Luiza Campos^ORCID,Moulik Srija,Walrad Pegine B.^ORCID,Chatterjee Mitali,Goto Hiro^ORCID,Wickremasinghe Renu,Lagos Dimitris^ORCID,Kaye Paul M.^ORCID,Ranasinghe Shalindra

Funder

UK Medical Research Council / UK Aid

Welcome Trust

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/142765/files/pdf

Reference38 articles.

1. The impact of leishmaniasis on mental health and psychosocial well-being: A systematic review

2. Leishmaniasis Worldwide and Global Estimates of Its Incidence

3. Drugs for Neglected Diseases Initiative. Cutaneous leishmaniasis. https://dndi.org/diseases/cutaneous-leishmaniasis/ Accessed October 4, 2021

4. Locally acquired cutaneous leishmaniasis in Sri Lanka;Athukorale;J Trop Med Hyg,1992

5. Sri Lankan cutaneous leishmaniasis is caused by Leishmania donovani zymodeme MON-37

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomized, double-blind phase 2b trial to evaluate efficacy of ChAd63-KH for treatment of post kala-azar dermal leishmaniasis;Molecular Therapy - Methods & Clinical Development;2024-09

2. A randomized double-blind Phase IIb trial to evaluate the efficacy of ChAd63-KH for the treatment of post kala-azar dermal leishmaniasis;2024-04-11

3. Evaluation of Less Invasive Sampling Tools for the Diagnosis of Cutaneous Leishmaniasis;Open Forum Infectious Diseases;2024-02-28

4. IL-32 producing CD8⁺memory T cells and Tregs define the IDO1 / PD-L1 niche in human cutaneous leishmaniasis skin lesions;2024-01-03

5. Characterisation of tumor microenvironment and prevalence of CD274/PD-L1 genetic alterations difference in colorectal Cancer;BMC Cancer;2023-03-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3